Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IN8BIO, INC.INAB · Entity 7941 | Chief Medical Officer | September 04, 2024 | September 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IN8BIO, INC.
Report date September 04, 2024 · Filed September 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.47 · Expires 2034-09-04 | Direct | 250,000 |
Reported balance
After 2024-09-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-09-04 · Grant · Acquired 250,000 · Balance 250,000 F1: Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2024 Filed Sep 5, 2024 16:35 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001415889-24-022924 · form4-09052024_040901.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2034-09-04 F1 · derivative.exercise_date: Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 16:50 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 176,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001415889-24-003019 · form4-02082024_090237.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,000 Underlying: Common Stock · 176,000 shares Expires 2034-02-07 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 08:20 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantSeries B Warrants (right to buy) · Derivative | 4,098 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001209191-23-058715 · doc4.xml · derivative · entry 3 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,098 Underlying: Common Stock · 4,098 shares Expires 2028-12-13 F1 · price: The reported securities are included within 4,098 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 4,098 shares of common stock. F2 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 08:20 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantSeries A Warrants (right to buy) · Derivative | 4,098 | Not disclosed Strike: $1.25 | Not disclosed |
DisclosureSEC source: 0001209191-23-058715 · doc4.xml · derivative · entry 2 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,098 Underlying: Common Stock · 4,098 shares Expires 2025-06-13 F1 · price: The reported securities are included within 4,098 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 4,098 shares of common stock. F2 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 08:20 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantCommon Stock | 4,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-058715 · doc4.xml · nonDerivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,729 F1 · price: The reported securities are included within 4,098 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 4,098 shares of common stock. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 18:29 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 134,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001209191-23-039510 · doc4.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,000 Underlying: Common Stock · 134,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 17:00 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001209191-23-024692 · doc4.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-04-14 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 16:32 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 68,427 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001209191-22-054506 · doc4.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,427 Underlying: Common Stock · 68,427 shares Expires 2032-10-21 F1 · derivative.exercise_date: The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 16:11 UTC | IN8BIO, INC. INAB · Entity 7941 | PurchaseCommon Stock | 2,631 | $1.90 | $4,998.90 |
DisclosureSEC source: 0001209191-22-046605 · doc4.xml · nonDerivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,631 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 16:39 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 90,500 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-22-010797 · doc4.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,500 Underlying: Common Stock · 90,500 shares Expires 2032-02-15 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 16:38 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001209191-21-066455 · doc4.xml · derivative · entry 1 Goswami Trishna · CIK 0001894243 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-11-19 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on November 19, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.